Latest reported quarter: Q2, ended Jun 2026 · reported in ARS
Quarter 2025/FY
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
| Line item | 2026 Q2 (ARS) |
2026 Q1 (ARS) |
2025 ANNUAL (ARS) |
2025 Q4 (ARS) |
2025 Q3 (ARS) |
|---|---|---|---|---|---|
| Total Revenue as Reported | ARS 696.61B | ARS 343.56B | ARS 1.10T | ARS 313.81B | ARS 319.59B |
| Total Operating Revenue | ARS 696.61B | ARS 343.56B | ARS 1.10T | ARS 313.81B | ARS 319.59B |
| Cost of Revenue | ARS 494.77B | ARS 202.06B | ARS 704.48B | ARS 218.67B | ARS 188.02B |
| Gross Profit | ARS 201.85B | ARS 141.51B | ARS 392.94B | ARS 95.14B | ARS 131.57B |
| Operating Expense | ARS 35.58B | ARS 31.95B | ARS 180.73B | ARS 124.47B | ARS 21.52B |
| Selling and Admin Expenses | ARS 36.50B | ARS 21.89B | ARS 80.59B | ARS 27.32B | ARS 18.15B |
| -General & Admin Expense | ARS 36.50B | ARS 21.89B | ARS 80.59B | ARS 27.32B | ARS 18.15B |
| Depreciation & Amortization & Depletion | ARS 993.60M | ARS 992.28M | ARS 3.74B | ARS 1.18B | ARS 931.07M |
| -Depreciation & Amortization | ARS 993.60M | ARS 992.28M | ARS 3.74B | ARS 1.18B | ARS 931.07M |
| Asset Impairment Loss | -ARS 340.13M | ARS 153.40M | – | – | ARS 152.72M |
| Other Taxes | -ARS 118,000.00 | ARS 8.51B | ARS 17.13B | ARS 5.26B | ARS 5.24B |
| Other Operating Expenses | -ARS 1.13B | ARS 363.47M | ARS 78.81B | ARS 90.82B | -ARS 3.05B |
| Operating Profit | ARS 166.26B | ARS 109.55B | ARS 212.21B | -ARS 29.33B | ARS 110.05B |
| Net Non-Operating Interest Income (Expense) | -ARS 17.12B | -ARS 14.09B | -ARS 25.76B | -ARS 7.06B | -ARS 7.42B |
| Non-Operating Interest Income | ARS 6.26B | ARS 5.54B | ARS 29.35B | ARS 10.06B | ARS 8.05B |
| Non-Operating Interest Expense | ARS 18.99B | ARS 18.09B | ARS 50.92B | ARS 16.25B | ARS 14.56B |
| Total Other Finance Costs | ARS 4.40B | ARS 1.53B | ARS 4.19B | ARS 871.82M | ARS 908.28M |
| Other Income (Expense) | ARS 29.79B | ARS 63.19B | ARS 266.58B | ARS 154.24B | ARS 16.44B |
| Gain on Sale of Security | ARS 23.23B | ARS 49.95B | ARS 140.38B | ARS 65.67B | ARS 23.88B |
| Earnings from Equity Interest | -ARS 1.10B | -ARS 843.02M | ARS 59.70B | ARS 4.42B | -ARS 335.73M |
| Special Income (Charges) | ARS 8.33B | ARS 14.69B | ARS 60.11B | ARS 53.56B | -ARS 311.98M |
| -Less:Other Special Charges | -ARS 7.10B | ARS 652.30M | -ARS 17.83B | -ARS 11.28B | ARS 311.98M |
| -Less:Write Off | -ARS 1.23B | -ARS 15.34B | ARS 930.61M | – | – |
| Other Non-Operating Income (Expenses) | -ARS 674.83M | -ARS 601.17M | ARS 6.39B | ARS 30.59B | -ARS 6.79B |
| Pretax Profit | ARS 178.93B | ARS 158.65B | ARS 453.03B | ARS 117.85B | ARS 119.07B |
| Tax | ARS 42.55B | -ARS 37.36B | ARS 100.18B | ARS 91.66B | -ARS 20.88B |
| Net Profit | ARS 136.38B | ARS 196.01B | ARS 352.85B | ARS 26.19B | ARS 139.95B |
| Profit from Continuing Operations | ARS 136.38B | ARS 196.01B | ARS 352.85B | ARS 26.19B | ARS 139.95B |
| Minority Interests | ARS 7.75B | ARS 8.47B | ARS 6.49B | ARS 3.34B | ARS 156.95M |
| Net Income to Parent Company | ARS 128.63B | ARS 187.54B | ARS 346.35B | ARS 22.85B | ARS 139.80B |
| Net Income to Common Stockholders | ARS 128.63B | ARS 187.54B | ARS 346.35B | ARS 22.85B | ARS 139.80B |
| Basic EPS | ARS 857.60 | ARS 1,250.40 | ARS 2,306.10 | ARS 152.80 | ARS 930.30 |
| Diluted EPS | ARS 857.60 | ARS 1,250.40 | ARS 2,306.10 | ARS 152.80 | ARS 930.30 |
| Dividend Per Share | ARS 0.00 | ARS 0.00 | ARS 0.00 | ARS 0.00 | ARS 0.00 |
| -Less:Restructuring and Mergern & Acquisition | – | – | ARS 0.00 | – | – |
| -Less:Impairment of Capital Assets | – | – | -ARS 60.95B | – | – |
| -Gain on Sale of Property/Plant/Equipment | – | – | -ARS 17.74B | -ARS 17.74B | ARS 0.00 |
| Line item | 2025 ANNUAL (ARS) |
2024 ANNUAL (ARS) |
2023 ANNUAL (ARS) |
2022 ANNUAL (ARS) |
2021 ANNUAL (ARS) |
|---|---|---|---|---|---|
| Total Assets | ARS 3.67T | ARS 3.50T | ARS 3.06T | ARS 1.19T | ARS 391.45B |
| Total Current Assets | ARS 722.37B | ARS 729.18B | ARS 636.98B | ARS 327.11B | ARS 90.92B |
| Cash and Cash Equivalents & Short-Term Investments | ARS 337.86B | ARS 321.00B | ARS 224.97B | ARS 158.78B | ARS 39.20B |
| -Cash and Cash Equivalents | ARS 37.68B | ARS 5.05B | ARS 29.33B | ARS 28.79B | ARS 548.79M |
| -Short Term Investments | ARS 300.18B | ARS 315.95B | ARS 195.63B | ARS 130.00B | ARS 38.65B |
| Receivables | ARS 328.59B | ARS 296.05B | ARS 364.91B | ARS 137.42B | ARS 46.44B |
| -Accounts Receivable | ARS 295.53B | ARS 272.20B | ARS 329.44B | ARS 109.71B | ARS 35.03B |
| -Taxes Receivable | ARS 10.63B | ARS 9.66B | ARS 7.33B | ARS 737.50M | ARS 2.12B |
| -Due from Related Parties Current | ARS 94.84M | ARS 109.11M | ARS 0.00 | ARS 181,000.00 | ARS 97,000.00 |
| -Other Receivables | ARS 22.83B | ARS 14.20B | ARS 28.22B | ARS 27.02B | ARS 9.32B |
| -Receivables Adjustments Allowances | -ARS 499.66M | -ARS 118.00M | -ARS 85.90M | -ARS 53.77M | -ARS 28.82M |
| Prepaid Assets | ARS 9.04B | ARS 35.26B | ARS 11.50B | ARS 1.80B | ARS 2.37B |
| Inventory | ARS 41.58B | ARS 74.93B | ARS 34.19B | ARS 28.86B | ARS 2.82B |
| Restricted Cash | ARS 2.45B | ARS 0.00 | – | – | – |
| Other Current Assets | ARS 2.84B | ARS 1.94B | ARS 1.41B | ARS 239.42M | ARS 96.49M |
| Total Non-Current Assets | ARS 2.95T | ARS 2.77T | ARS 2.42T | ARS 862.29B | ARS 300.53B |
| Net PPE | ARS 2.35T | ARS 2.13T | ARS 1.65T | ARS 616.32B | ARS 215.49B |
| -Gross PPE | ARS 4.57T | ARS 4.30T | ARS 3.09T | ARS 1.26T | ARS 392.74B |
| -Accumulated Depreciation | -ARS 2.23T | -ARS 2.17T | -ARS 1.44T | -ARS 643.67B | -ARS 177.25B |
| Investments and Advances | ARS 213.16B | ARS 163.43B | ARS 159.19B | ARS 41.49B | ARS 12.34B |
| -Available for Sale Securities | ARS 184.57B | ARS 19.68B | ARS 860.37M | ARS 211.56M | ARS 67.94M |
| -Long Term Equity Investment | ARS 28.60B | ARS 143.75B | ARS 74.82B | ARS 37.86B | ARS 12.27B |
| Non Current Accounts Receivables | ARS 128.99B | ARS 180.78B | ARS 337.31B | ARS 132.54B | ARS 59.93B |
| Non-Current Prepaid Assets | ARS 10.71B | ARS 5.81M | ARS 9.92M | ARS 14.18M | ARS 8.87M |
| Goodwill and Other Intangible Assets | ARS 40.47B | ARS 40.41B | ARS 34.75B | ARS 24.21B | ARS 11.76B |
| -Other Intangible Assets | ARS 40.47B | ARS 40.41B | ARS 34.75B | ARS 24.21B | ARS 11.76B |
| Non-Current Deferred Assets | ARS 4.18B | ARS 8.45B | ARS 27.58B | ARS 2.60B | ARS 256.26M |
| Other Non-Current Assets | ARS 204.25B | ARS 251.36B | ARS 207.36B | ARS 45.11B | ARS 743.55M |
| Total Liabilities | ARS 1.05T | ARS 1.05T | ARS 1.19T | ARS 375.52B | ARS 144.46B |
| Total Current Liabilities | ARS 407.48B | ARS 492.94B | ARS 321.98B | ARS 132.35B | ARS 33.11B |
| Payables | ARS 236.40B | ARS 270.08B | ARS 180.02B | ARS 66.50B | ARS 16.71B |
| -Accounts Payable | ARS 124.20B | ARS 124.29B | ARS 107.84B | ARS 22.99B | ARS 5.16B |
| -Total Tax Payable | ARS 86.75B | ARS 117.08B | ARS 68.19B | ARS 39.02B | ARS 11.03B |
| -Due to Related Parties Current | ARS 0.00 | ARS 1.81B | ARS 617.46M | ARS 387.23M | ARS 139.14M |
| -Other Payable | ARS 25.44B | ARS 26.91B | ARS 3.37B | ARS 1.16B | ARS 378.12M |
| Short-Term Debt and Capital Lease Obligation | ARS 144.09B | ARS 198.35B | ARS 106.29B | ARS 56.63B | ARS 12.28B |
| -Current Debt | ARS 144.09B | ARS 198.35B | ARS 106.29B | ARS 56.63B | ARS 12.28B |
| Current Provisions | ARS 3.89B | ARS 3.87B | ARS 3.54B | ARS 143.61M | ARS 174.70M |
| Other Current Liabilities | ARS 2.69B | ARS 55.39M | ARS 1.25B | ARS 201.59M | ARS 1.15B |
| Total Non-Current Liabilities | ARS 646.19B | ARS 558.06B | ARS 868.57B | ARS 243.17B | ARS 111.35B |
| Long Term Accounts Payable and Other Payables | ARS 21.74B | ARS 33.49B | ARS 61.14B | ARS 23.58B | ARS 10.55B |
| Long Term Debt and Capital Lease Obligation | ARS 348.94B | ARS 302.58B | ARS 623.62B | ARS 140.88B | ARS 69.82B |
| -Long Term Debt | ARS 348.94B | ARS 302.58B | ARS 623.62B | ARS 140.88B | ARS 69.82B |
| Non-Current Liabilities | ARS 18.43B | ARS 2.96B | ARS 4.21B | ARS 184.89M | ARS 93.85M |
| Non-Current Deferred Liabilities | ARS 247.38B | ARS 208.95B | ARS 172.39B | ARS 76.20B | ARS 29.56B |
| Employee Benefits | ARS 9.71B | ARS 10.09B | ARS 7.21B | ARS 2.32B | ARS 665.87M |
| Total Equity | ARS 2.62T | ARS 2.45T | ARS 1.87T | ARS 813.88B | ARS 246.99B |
| Stockholders' Equity | ARS 2.55T | ARS 2.37T | ARS 1.82T | ARS 813.26B | ARS 246.66B |
| Capital Stock | ARS 561.08B | ARS 706.34B | ARS 541.02B | ARS 248.44B | ARS 79.78B |
| -Common Stock | ARS 561.08B | ARS 706.34B | ARS 541.02B | ARS 248.44B | ARS 79.78B |
| Gains/Losses Not Affecting Retained Earnings | ARS 1.71T | ARS 1.64T | ARS 1.00T | ARS 524.10B | ARS 174.09B |
| Other Equity Interests | ARS 284.50B | ARS 18.21B | -ARS 49.06B | -ARS 18.09B | -ARS 5.78B |
| Minority Interests | ARS 64.80B | ARS 82.95B | ARS 47.37B | ARS 616.61M | ARS 331.37M |
| Current Accrued Expenses | – | – | ARS 16.92B | ARS 4.30B | ARS 1.21B |
| Retained Earnings | – | – | ARS 322.33B | ARS 58.82B | -ARS 1.43B |
| -Dividends Payable | – | – | – | ARS 2.95B | ARS 0.00 |
| Derivative Product Liabilities | – | – | – | – | ARS 663.11M |
No comments yet — be the first to weigh in on CEPU.